摘要
目的探讨SB239063,新一代p38丝裂原活化蛋白激酶抑制剂(p38MAPK)在缺氧缺糖(OGD)所致SHSY5Y细胞损伤中的作用。方法体外培养SHSY5Y神经母细胞瘤株,以缺氧缺糖、SB239063(10μmol/L)处理,以MTT检测SHSY5Y细胞活性,以Westernblot方法检测p38MAPK活性,应用HEt和fluo-3/AM的荧光强度测定OGD后SHSY5Y细胞超氧化物阴离子和钙离子的浓度。结果SB239063能提高OGD后SHSY5Y细胞的活性(P<0.01),降低OGD后p38MAPK活性(P<0.05),HEt(P<0.05)和fluo-3/AM荧光强度(P<0.01)。结论SB239063通过抑制p38MAPK的激活,降低细胞内超氧阴离子的浓度,进而抑制细胞内钙超载,从而达到保护SHSY5Y细胞对抗OGD的细胞损害的作用。
Objective To investigate the neuroprotective effect of SB239063,the new p38 mitogen-activated protein kinase (MAPK) inhibitor on SHSYSY neuronal cells against oxygen-glucose deprivation (OGD), and the mechanisms of the neuroprotective effect. Methods SHSYSY neuroblastoma cells were exposed to OGD with or without SB239063 ( 10μmol/L) , cell viability was measured by the MTT assay, activity of p38MAPK was measured by western blot, intracellu- lar concentration of superoxide anion and calcium were evaluated via the fluorescence intensity of HEt and fluo-3/AM. Resuits Compared with the OGD group, the MTr value was elevated significantly in the SB239063 group (P 〈 0.01 ), the activity of p38MAPK decreased significantly in the SB239063 group ( P 〈 0.01 ), the fluorescence intensity of HEt ( P 〈 0.05) and fluo-3/AM (P 〈 0.01 ) decreased significantly in the SB239063 group. Conclusion SB239063 protects SHSY5Y neuronal cells against OGD by inhibiting the activity of p38MAPK,then reducing the intracellular concentration of superoxide anion and calcium.
出处
《中风与神经疾病杂志》
CAS
CSCD
北大核心
2009年第3期277-279,共3页
Journal of Apoplexy and Nervous Diseases
基金
深圳市科技局资助项目(200702029和200702030)
广东省医学科学技术研究基金资助项目(A2008601和A2007570)